Guidelines for the management of adult myelodysplastic syndromes

被引:17
|
作者
Killick, Sally B. [1 ]
Ingram, Wendy [2 ]
Culligan, Dominic [3 ]
Enright, Helen [4 ]
Kell, Jonathan [2 ]
Payne, Elspeth M. [5 ]
Krishnamurthy, Pramila [6 ]
Kulasekararaj, Austin [6 ]
Raghavan, Manoj [7 ]
Stanworth, Simon J. [8 ,9 ]
Green, Simone [10 ]
Mufti, Ghulam [6 ]
Quek, Lynn [6 ]
Cargo, Catherine [11 ]
Jones, Gail L. [12 ]
Mills, Juliet [13 ,14 ]
Sternberg, Alex [15 ]
Wiseman, Daniel H. [16 ]
Bowen, David [11 ]
机构
[1] Univ Hosp Dorset NHS Fdn Trust, Royal Bournemouth Hosp, Bournemouth, Dorset, England
[2] Univ Hosp Wales, Cardiff, Wales
[3] Aberdeen Royal Infirm, Aberdeen, Scotland
[4] Trinity Coll Dublin, Tallaght Univ Hosp, Med Sch, Dublin, Ireland
[5] UCL, Canc Inst, London, England
[6] Kings Coll Hosp NHS Fdn Trust, London, England
[7] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[8] Univ Oxford, Oxford Univ Hosp NHS Trust, Oxford, England
[9] NHS Blood & Transplant, Oxford, England
[10] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[11] Leeds Teaching Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England
[12] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[13] Worcestershire Acute Hosp NHS Trust, Worcester, England
[14] Birmingham NHS Fdn Trust, Worcester, England
[15] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England
[16] Christie NHS Fdn Trust, Manchester, Lancs, England
关键词
myelodysplastic syndromes; MDS; guideline; management; STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; TRANSFUSION-DEPENDENT PATIENTS; CONVENTIONAL CARE REGIMENS; PROGNOSTIC SCORING SYSTEM; COLONY-STIMULATING FACTOR; IRON CHELATION-THERAPY; RANDOMIZED PHASE-III; LABILE PLASMA IRON; RISK MDS PATIENTS;
D O I
10.1111/bjh.17612
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:267 / 281
页数:15
相关论文
共 50 条
  • [41] Current State of the Art: Management of Higher Risk Myelodysplastic Syndromes
    Komrokji, Rami S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 : S39 - S43
  • [42] Infections in myelodysplastic syndromes
    Toma, Andrea
    Fenaux, Pierre
    Dreyfus, Francois
    Cordonnier, Catherine
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (10): : 1459 - 1470
  • [43] Transplantation strategies for the management of patients with myelodysplastic syndromes
    Meletis, J.
    Terpos, E.
    JOURNAL OF BUON, 2009, 14 (04): : 551 - 564
  • [44] Role of reactive oxygen species in myelodysplastic syndromes
    Jing, Qiangan
    Zhou, Chaoting
    Zhang, Junyu
    Zhang, Ping
    Wu, Yunyi
    Zhou, Junyu
    Tong, Xiangmin
    Li, Yanchun
    Du, Jing
    Wang, Ying
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2024, 29 (01)
  • [45] Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly
    Klepin, Heidi D.
    CLINICS IN GERIATRIC MEDICINE, 2016, 32 (01) : 155 - +
  • [46] Myelodysplastic Syndromes: Therapy and Outlook
    Lyons, Roger M.
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (07) : S18 - S23
  • [47] Recent developments in myelodysplastic syndromes
    Bejar, Rafael
    Steensma, David P.
    BLOOD, 2014, 124 (18) : 2793 - 2803
  • [48] Role of Bcl-2 inhibition in myelodysplastic syndromes
    Blum, Sabine
    Tsilimidos, Gerasimos
    Bresser, Helena
    Luebbert, Michael
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (08) : 1526 - 1535
  • [49] Evolving therapies for lower-risk myelodysplastic syndromes
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    ANNALS OF HEMATOLOGY, 2020, 99 (04) : 677 - 692
  • [50] The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes
    Abou Zahr, Abdallah
    Aldin, Ehab Saad
    Barbarotta, Lisa
    Podoltsev, Nikolai
    Zeidan, Amer M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1019 - 1036